Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients.
about
Role of genetic detection in peritoneal washes with gastric carcinoma: The past, present and futureFree intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysisThe evolving role of catumaxomab in gastric cancerAberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancerRetrospective comparative study of the effects of dendritic cell vaccine and cytokine-induced killer cell immunotherapy with that of chemotherapy alone and in combination for colorectal cancer.Clinical significance of zinc-finger E-box binding homeobox 1 mRNA levels in peritoneal washing for gastric cancer.Prognostic Significance of Molecular Analysis of Peritoneal Fluid for Patients with Gastric Cancer: A Meta-Analysis.Prediction of tumor recurrence after curative resection in gastric carcinoma based on bcl-2 expression.A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer.Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer: a meta-analysis.Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysisEstablishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway.Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resectionCirculating methylated MINT2 promoter DNA is a potential poor prognostic factor in gastric cancer.
P2860
Q26753850-09004A34-83B8-4BCE-91BA-D42D825B3C31Q26783309-E81F210A-096D-4BA8-A9E9-38CE3239A044Q28290511-D8353282-BC96-47C4-AAFC-89AA829217C1Q33596504-E099E2DD-1093-4B31-92A6-A6F843578BC2Q34119366-EA64F9D5-F56A-4029-89F0-AC4F920926ACQ35180005-A4B3EDC8-0930-4E73-9359-9171886A09ABQ35961219-00D0397A-9F1B-48BD-8D33-C13573A22209Q37717333-C85E266A-D51D-4EE7-9EBD-969C64B876A5Q37910040-BED14A0D-256D-4B4C-A405-A2E5A6E33100Q38174806-A4C118F9-9744-4D8A-84C0-1AF212F72B1AQ39079745-157487C1-A5C4-4FDB-B949-B668C24440BEQ39373538-A22D549B-6F2E-409A-92D6-6530085EC45DQ39399913-182BF158-1021-4576-BCE0-E66B19F274A3Q42014882-1197BE0E-17B5-4046-BCF5-DB1CC842D0CDQ55057577-3DB18CF0-3723-4C98-A945-A1B6C3B479C6
P2860
Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prospective validation of quan ...... in gastric carcinoma patients.
@ast
Prospective validation of quan ...... in gastric carcinoma patients.
@en
type
label
Prospective validation of quan ...... in gastric carcinoma patients.
@ast
Prospective validation of quan ...... in gastric carcinoma patients.
@en
prefLabel
Prospective validation of quan ...... in gastric carcinoma patients.
@ast
Prospective validation of quan ...... in gastric carcinoma patients.
@en
P2093
P2860
P356
P1476
Prospective validation of quan ...... in gastric carcinoma patients.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602802
P407
P577
2005-10-01T00:00:00Z